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Abstract
Background: Follow-up studies revealed that subjects with borderline personality disorder (BPD) present high rates
of clinical remission, although psychosocial functioning often remains impaired. The aim of this study is to evaluate
the efficacy of a cognitive rehabilitation intervention versus a psychoeducational program on psychosocial
functioning in subjects with BPD.
Methods: A multicenter, randomized, and positive-controlled clinical trial was conducted. Seventy outpatients with
BPD were randomized to cognitive rehabilitation or psychoeducational group interventions. Participants were
evaluated after completion of the intervention period (16 weeks) and after the follow-up period (6 months).
Psychosocial functioning, clinical and neuropsychological outcomes were evaluated.
Results: No main effects of group or group x time were observed on functionality but a significant effect of time
was found. Post-hoc analyses showed that only cognitive rehabilitation increased psychosocial functioning significantly
at endpoint. Psychoeducation showed a significant enhancement of depressive symptoms.
Conclusions: Cognitive rehabilitation and psychoeducational interventions appeared to show good efficacy in
improving disabilities in daily life in subjects with BPD. These interventions are easily implemented in mental health
settings and have the advantage of improving general functioning and clinical symptoms.
Trial registration: Clinicaltrials.gov:NCT02033044. Registered 9 January 2014
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Background
Borderline Personality Disorder (BPD) is a common and
severe disorder that has long been considered a chronic
and untreatable disorder for many clinicians [1, 2]. Never-
theless, recent long follow-up studies offer a more optimis-
tic scenario indicating high rates of clinical remission
[2–4]. However, remission does not appear to be equiva-
lent to full recovery as symptoms improvement is not ne-
cessarily associated with amelioration of psychosocial
dysfunctioning. These same studies point out that the chal-
lenge for the next generation of therapies is to redirect the
focus onto improving functional outcomes as well as clin-
ical symptoms [2–4]. Most psychotherapies such as Dia-
lectical Behaviour Therapy (DBT) or Mentalization Based
Therapy have proven their efficacy to treat emotional
dysregulation, impulsivity and interpersonal difficulties, but
not cognitive deficits or psychosocial functioning [1].
It is often accepted that psychosocial dysfunction is
partly caused by cognitive deficits that remained impaired
after clinical remission in other mental disorders such as
schizophrenia and bipolar disorder [5, 6], but there are
few studies addressing this issue in BPD. Some recent
studies have established that neuropsychological dysfunc-
tion of BPD might be affecting domains such as attention,
cognitive flexibility, memory, planning, processing speed
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and visuo-spatial skills [7–10]. Accordingly, recent neuro-
imaging studies in BPD have reported structural and func-
tional abnormalities in many brain areas supporting the
assumption of a dysfunctional frontolimbic network in
subjects with BPD [1, 11–15]. Such abnormalities are
compatible with the cognitive impairment observed in
BPD patients [7–10]. Nevertheless, some authors suggest
that these neurocognitive dysfunctions in BPD may owe
more to the impact of transient mood states or emotional
distress than to underlying primary cognitive deficits per
se [16, 17].
Cognitive rehabilitation strategies have usually been ap-
plied in schizophrenia [18], and, more recently, their effi-
cacy has been demonstrated in affective disorders [19, 20].
To our knowledge, there are no consistent data on the ap-
plication of neuropsychological remediation in patients
with BPD, apart from preliminary communications of posi-
tive findings in case series [21, 22]. The aim of the present
randomized and controlled study is to evaluate the efficacy
of a cognitive rehabilitation group therapy as compared to
a psychoeducational group intervention in subjects with
BPD on psychosocial functioning.
Method
Participants
A total of 70 outpatients with BPD were included from
September 2011 to July 2013, 30 from the Hospital Clinico
San Carlos, 20 from the Hospital Santa Creu i Sant Pau,
and 20 from the Hospital Ramón y Cajal. Inclusion criteria
were the following: 1) Outpatients aged 18 to 45 years; 2)
Diagnoses of BPD according to DSM-IV-TR [23] criteria
and evaluated by two semi-structured diagnostic inter-
views -Structured Clinical Interview for DSM-IV Axis II
Disorders (SCID-II) [24] and the Revised Diagnostic Inter-
view for Borderlines (DIB-R) [25]-to guarantee a correct
diagnosis; 3) Clinical severity measured with Clinical
Global Impression for BPD (CGI-BPD) [26] higher than 4;
and 4) Functional impairment measured with a Global
Assessment Functioning (GAF) [23] lower than 65.
Exclusion criteria were the following: 1) Severe physical
conditions, such as organic brain syndrome or neuro-
logical disease that could affect neuropsychological per-
formance; 2) Intelligence Quotient IQ < 85; 3) Major
Depression Disorder (MDD) or substance misuse within
the last 6 months evaluated with DSM-IV criteria and
SCID-I specific sections; 4) DSM-IV criteria for Schizo-
phrenia, severe psychotic disorder or bipolar disorder
evaluated by SCID-I specific sections; 5) Previous par-
ticipation in any psychoeducation or cognitive rehabili-
tation intervention.
Study design and procedure
Study design was a multicenter, randomized, rater-blind
clinical trial (see Additional file 1: Figure S1). There were
two-parallel arms (1:1) to evaluate functional, clinical and
cognitive efficacy of a specific cognitive rehabilitation group
intervention (CR) compared with a psychoeducational
group intervention (PE) in subjects with BPD. To ensure
the reliability among centers regarding the evaluation and
the treatment fidelity, two meetings were organized before
the start of the study to train therapists.
Clinical and neuropsychological evaluations before inter-
ventions were administered on different days since they
lasted in general more than one hour each and the effect of
fatigue or boredom might have affected the results. Experi-
enced psychiatrists and psychologists performed clinical in-
terviews over 3 months to ensure the follow-up of all
participants prospectively. The following sociodemographic
and clinical variables were collected: age at recruitment,
gender, education level, occupational status, and pharma-
cological treatment. All participants were randomized to
receive CR or PE in a 1:1 ratio stratified by centre, age, and
education level. Generation of random allocation sequence
was done with the Research Randomizer (www.randomizer.
org). The present study was powered to test hypotheses
about potential between-treatment differences on the pri-
mary outcome. With a sample size of 70 and an expected
attrition from assessments of 30 %, the study had power
of 65 % and a level of significance of 5 % to detect a
moderate effect (d = .6).
Participants were evaluated at baseline, after the interven-
tion (16-week period), and after the follow-up period (six
months after the intervention). During the whole study
period, subjects did not receive any other individual or
group psychotherapy. All patients continued pharmaco-
logical treatment if it had been initiated prior to inclusion.
Type and doses of medication could not be modified at any
time during the whole study period. Both interventions
were applied in a group format and were conducted by two
psychologists with experience in managing patients with
BPD. Subjects were instructed not to disclose any informa-
tion about the intervention to maintain blind conditions.
Adverse events such as severe self-harm, suicide attempt,
hospitalization and death during the trial were collected.
Ethics
The study was approved by the Ethics Committee of the
Hospital Clínico San Carlos and carried out in accordance
with the ethical principles of Declaration of Helsinki. All
subjects received extensive information about the study
and provided written informed consent before they were
enrolled in the study. This study was registered at clinical-
trials.gov (NCT02033044).
Interventions
Cognitive Rehabilitation (CR)
CR consisted of group sessions (5 individuals per group)
of 120 min, twice a week during a total period of 16 weeks
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(32 sessions). The exercises addressed neurocognitive is-
sues related to sustained attention, processing speed,
memory and executive functioning. The whole program
aimed at getting new strategies to improve functional
adaptation, thus tasks were carried out in the clinical set-
ting and at home. Some homework tasks were based on
their daily life difficulties and problems. The main object-
ive of this program was the generalization of rehabilitated
cognitive functions to daily life activities. Most of the tech-
niques were based on a previous program for bipolar dis-
order [20].
Psychoeducation (PE)
The psychoeducational intervention consisted of 16
weekly group sessions of 5 individuals of 120 min each
(16 sessions). This therapy aimed at improving aware-
ness of illness, interpersonal abilities, family balance,
therapeutical adherence, emotional management in
frustrating situations, problem solving, and lifestyle re-
gularity. During this intervention, no homework tasks
were required. This intervention was based on the first
step of the Systems Training for Emotional Predictabil-
ity and Problem Solving (STEPPS) program: “Aware-
ness of Borderline Personality Disorder” [27]. Any
other STEPPS’s contents were included in this psychoe-
ducation intervention. In order to provide a more
rigorous comparison condition and for controlling
nonspecific effects of the CR (e.g., attending in a regu-
lar basis to a group therapy), PE was elected instead of
other common comparisons such as treatment as usual
(TAU) or waiting list.
Instruments
Diagnostic interviews and severity assessment
– Structured Clinical Interview for DSM-IV Axis II Per-
sonality Disorders (SCID-II) [24]. A semi-structured
interview to assess personality disorders according
to DSM-IV criteria. The Spanish version has good
discrimination between Axis II personality disorders,
as well as good reliability between raters as indicated
by an overall Kappa of 0.85.
– Revised Diagnostic Interview for Borderlines (DIB-R)
[25]. The DIB-R is a semi-structured interview that
brings the diagnosis of BPD within the last two
years. Scores range from 0 (no BPD severity) to 10
(high BPD severity). The Spanish version has shown
good psychometric properties regarding internal
consistency (Cronbach’s alpha: 0.89), sensitivity
(0.81) and specificity (0.94). The interviewers were
experienced psychologists and presented a high
inter-rater reliability (within-class correlation: 0.94).
The inter-test-reliability of DIB-R and SCID-II was
moderate (Kappa: 0.59).
– Clinical Global Impression Scale for BPD (CGI-BPD)
[26]. This clinician-rated scale assesses global severity
for BPD and symptomatic dimensions using a 7-point
Likert scale, which ranges from 1 (absence of illness)
to 7 (high severity of illness).
– Global Assessment Functioning (GAF) [23], from the
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition Text Revision (DSM-IV-TR). This scale
allows the evaluation of the global functioning of the
patient and ranges from 1 to 100.
Primary outcome: psychosocial functioning
– Functioning Assessment Scale Test (FAST) [28]. This
was the primary outcome measure. It is a 24-item
clinician-rated scale that measures the level of func-
tioning of patients in daily life situations in the past
two weeks. It assesses six functional domains: auton-
omy, occupational functioning, cognitive function-
ing, financial issues, interpersonal relationships, and
leisure time. Scores range from 0 (none) to 3 (higher
functional impairment). This instrument has shown
good psychometric properties and sensitivity to
change.
Secondary outcomes: clinical and neuropsychological
effects
Clinical assessment
– Borderline Symptom List – 23 (BSL-23) [29]. A 23-
item self-rating instrument used to assess the typical
symptomatology and severity of BPD. It is rated by
using a 5-point scale from 0 (“not at all”) to 4 (“very
strong”). This instrument has shown good psycho-
metric properties.
– Hamilton Anxiety Rating Scale (HARS) [30]. It is a
clinician-rated scale to evaluate current anxious
symptoms.
– Montgomery-Asberg Depression Rating Scale
(MADRS) [31]. This is a self-rated questionnaire for
the evaluation of depression severity.
– Barrat Impulsivity Scale (BIS) [32]. This is a 30-item
self-rated scale to assess behavioral impulsivity.
Neuropsychological assessment
Subjects were evaluated with a complete neuropsycho-
logical battery based on the literature from previous re-
search that explored cognitive functions in subjects with
BPD [7–10]. The estimated IQ was evaluated with the
WAIS-III vocabulary subtest. The battery consisted of
several tests to evaluate three different domains: atten-
tion, memory, and executive function. In order to sum
up redundant neuropsychological tests assessing these
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domains, three indexes were further calculated with com-
posite score.
1. Attention Index. This was calculated by summing
standarized scores obtained from the Symbol Digit
Modality Test [33] to evaluate sustained attention and
processing speed test and the inverse standarized
values from Trail Making Test A [34], which requires
visual exploration, numeric ordenation and viso-
motor speed.
2. Memory Index. This was calculated by means of the
standardized scores from the Buschke Selective
Reminding Test [35], which explores immediate
declared verbal and delayed memory.
3. Executive index. This index was calculated by
summing standardized scores from different tests
such as Controlled Oral Word Association Test
(COWAT-FAS) [36] to assess verbal fluency; Trail
Making Test B [34] to assess cognitive flexibility;
Direct and Inverse Digit tests [37] to assess working
memory; Stroop Colour-Word Interference Test [38]
to evaluate inhibition control; and finally, number of
categories from the Wisconsin Card Sorting Test
(WCST) [39] to assess the capacity of abstraction, cog-
nitive flexibility, elaboration of concepts and planning.
Statistical analysis
All analyses were performed with the SPSS 19.0 software
package for Windows and all hypotheses were tested
with a two-sided significance level of 0.05. First, descrip-
tive analyses were performed using chi-square test for
categorical variables and t-test for continuous variables.
Given the high number of dropouts in post-intervention
and follow-up, the planned repeated measures ANOVA
was substituted by the Hierarchical Linear Modeling
(HLM) to investigate treatment, time and the interaction
with the MIXED procedure of SPSS [40]. Post hoc ana-
lyses were performed with HLM to evaluate group-
specific changes related to intervention. Subjects were
included only if they had baseline measure and at least
one post-baseline measure and all analyses were con-
ducted on an intention-to-treat basis. The primary out-
come was the change in total score of FAST but this
same procedure was applied to test changes on clinical
and neuropsychological variables.
Results
Sociodemographics and clinical characteristics
Patient flow is presented in Fig. 1. A total of 88 partici-
pants were evaluated over 20 months, 18 of whom were
not included for different reasons (refusal to participate,
language difficulties, no longer meeting study criteria
and lost to follow-up). Finally, 70 individuals were ran-
domized (1:1): 36 participants (51 %) to the CR arm and
34 (49 %) to the PE arm. During the intervention, 28
subjects discontinued the study without differences be-
tween groups, 16 subjects (44 %) dropped out the CR
and 12 (35 %) dropped out in the case of the PE. The
most reported cause for abandoning was “patient’s desire
to drop out of the study” (Fig. 1). There were no signifi-
cant differences at baseline between individuals that
finalized the intervention and those that dropped out in
terms of demographic and clinical characteristics.
As shown in Table 1, there were no significant differ-
ences between the two interventions at baseline in terms
of demographic characteristics, clinical severity or pharma-
cological treatment. The majority of individuals were
women (74 %) and more than 40 % of the sample had a
long-term sick-leave. The sample had a moderate to severe
clinical profile and a poor psychosocial functioning. Most
participants were taking pharmacological treatment and
had participated in previous psychotherapies (mainly
Dialectical Behaviour Therapy) but did not have previous
experience in cognitive rehabilitation or psychoeducation
programme.
Primary outcome
Psychosocial functional improvement
Table 2 presents a summary of mean scores corresponding
to pre- and post-intervention as well as 6-month follow-up
measurements. HLM was carried out including number of
sessions as a covariable and main effects can be found in
Table 2. The primary outcome of the trial (FAST) did not
show main effects of group, group x time or number of
sessions. There was a significant main effect of time for
both treatments (baseline, post-treatment, and 6-month
follow-up assessments) [F(2, 40.04) = 6.34, p = .004]. Post
hoc analyses showed that CR was the intervention which
showed greater improvement in the FAST (p = .018)
(Fig. 2).
Secondary outcomes
Clinical improvement
No significant changes related to CR or PE were ob-
served in BPD psychopathology measured by BSL-23
(p > .6). Regarding impulsivity measured by BIS, no
significant differences were observed either (p = .1).
Significant time effects were observed in the HLM ana-
lyses for HARS [F(2, 46.29) = 9.29, p < .001] and
MADRS [F(2,45.63) = 8.92, p < .001]. An effect of group
[F(1, 64.14) = 7.37, p = .009] and a tendency for group x
time [F(2, 45.63) = 2.96, p = .062] was also found in
MADRS scores. Post hoc analyses indicated significant
improvements on anxiety and depression in PE group
(p = .006 and p < .001, respectively) and on anxiety in
the CR group (p = .023).
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Neuropsychological improvement
No effect of the interventions was found for the Mem-
ory and Executive Indexes (p > .05). Regarding the At-
tention Index, a group x time interaction was found
[F(2, 39.66) = 4.33, p = .02], although post hoc tests indi-
cated no significant differences in Attention Index
(p > .05).
Discussion
This is the first randomized clinical trial that evaluates
the efficacy and long-term effects of a cognitive rehabilita-
tion group intervention compared with a psychoeduca-
tional group intervention in subjects with borderline
personality disorder. The results show that cognitive
rehabilitation exerted the greatest change on the primary
outcome six months after the intervention finished but not
at its end, demonstrating long-term effects of cognitive
remediation. By contrast, psychoeducational intervention
also showed a significant enhancement of depressive symp-
toms and attention functioning.
It has been suggested that cognitive remediation pro-
grams for psychiatric disorders should aim at improving
general functioning beyond cognition [41]. As in a previous
trial with patients suffering bipolar disorder [20], inclusion
criteria of the present study required functional disability
of patients in their daily activities but not necessarily an
impaired cognitive profile. Therefore, this could explain
the beneficial effects of cognitive rehabilitation on psycho-
social functioning without observing neuropsychological
changes, neither at the end of the intervention nor in the
Fig. 1 The CONSORT diagram shows the randomization of patients to cognitive rehabilitation or psychoeducation and the progress through the study
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follow-up assessment. Strikingly, our results showed that
some cognitive deficits, as measured with neuropsycho-
logical tests, remained unchanged after cognitive rehabili-
tation although patients exhibited fewer difficulties and
better functioning after intervention, regardless of whether
it was cognitive rehabilitation or psychoeducation. This
was unexpected, as the hypothesis was that enhancement
of cognitive functioning should have accounted for im-
provements in functional outcomes, at least in part. Two
explanations are possible: the deficits of these patients were
too mild to be improved with the programs or there may
have been a type II error, i.e., the sample was not big
enough to detect differences in neuropsychological data.
Alternatively, and considering recent evidences [16, 17], it
is also possible that the neuropsychological performance of
subjects with BPD would be affected by emotional distress.
Further studies that evaluate intervention effects on the
cognitive function in BPD should control for this variable.
In any case, cognitive rehabilitation emphasized the use of
compensatory skills to cope with daily life difficulties. Psy-
choeducational intervention would have exerted similar
effects as patients acquired deeper insight into their illness
and new strategies to cope with stress.
Amongst psychiatric disorders, neurocognitive rehabili-
tation has been efficiently tested for schizophrenia with
the Integrated Psychological Therapy or IPT [42] and the
Cognitive Remediation Therapy or CRT [18]. More re-
cently, it has been tested for affective and bipolar disorders
with significant efficacy [19, 20]. To date, there are no
consistent data on neuropsychological remediation for
subjects with BPD and only preliminary and uncontrolled
communications of positive experiences have been pub-
lished [21, 22]. No significant differences between CR and
PE were found, but both interventions improved general
functioning, which provides evidence of the need for
therapeutic strategies focused on psychosocial difficulties
of psychiatric patients. The lack of an inactive arm such as
Table 1 Summary of demographics and clinical variables at
baseline
CR (n = 36) PE (n = 34) P
Gender (n/% females) 28/77.8 24/70.6 n.s.
Age 32.4 (6.04) 32.8 (8.8) n.s.
Years of education 11.78 (4.12) 11.0 (3.33) n.s.
Sick-leave/Unemployed (n/%) 16/44.4 13/38.2 n.s.
DIB-R 7.65 (1.35) 7.33 (1.31) n.s.
GAF 54.74 (7.45) 56.03 (8.94) n.s.
CGI-BPD 4.94 (0.79) 4.74 (0.93) n.s.
Pharmacological treatment (n/%) 27 (75) 23 (67.6) n.s.
Antidepressant 24 (66.7) 22 (64.7) n.s.
Benzodiazepine 16 (44.4) 13 (38.2) n.s.
Mood Stabilizer 20 (55.6) 13 (38.2) n.s.
Antipsychotic 11 (30.6) 11 (32.4) n.s.
Note: Values represent mean scores (SD between brackets) or otherwise
specified. No significant differences between groups were observed in χ2 test
for categorical variables neither in t-test for quantitative ones (n.s)
Sick-leave/Unemployed: long-term sick-leave (>3 months) or for being unemployed,
DIB-R Diagnostic Interview for Borderlines-Revised, GAF Global Assessment
Funcioning, CGI-BPD Clinical Global Impression Scale for BPD
Table 2 Summary of pre- post-intervention and 6-months follow-up measures and significant interactions on HLM analysis
CR PE
Baseline
(n = 36)
Post-treatment
(n = 22)
Follow-up
(n = 20)
Post-hoc
tests
Baseline
(n = 34)
Post-treatment
(n = 24)
Follow-up
(n = 22)
Post-hoc
tests
HLM
Group Time Group
x time
Psychosocial Functioning
FAST 37.86 (1.81) 36.86 (2.55) 29.55 (2.92) p = .018 42.94 (1.89) 38.01 (2.51) 35.61 (3.03) n.s. n.s. p = .004 n.s.
Clinical variables
BSL-23 42.32 (3.90) 42.56 (5.00) 34.91 (5.25) n.s. 40.42 (4.14) 38.89 (4.86) 39.59 (5.53) n.s. n.s. n.s. n.s.
HARS 24.89 (1.94) 19.76 (2.62) 16.53 (2.61) p = .023 21.60 (2.02) 18.61 (2.65) 11.52 (2.87) p = .006 n.s. p < .001 n.s.
MADRS 22.54 (1.60) 19.16 (1.83) 20.02 (1.98) n.s. 18.67 (1.65) 16.58 (1.85) 9.91 (2.13) p < .001 p = .009 p < .001 n.s.
BIS 64.53 (2.70) 65.93 (3.34) 57.14 (4.04) n.s. 70.59 (2.84) 67.92 (3.33) 67.06 (4.35) n.s. n.s. n.s. n.s.
Neuropsychological variables
Memory
Index
–.10 (.11) –.13 (.09) –.15 (.11) n.s. .20 (.11) .01 (.09) .11 (.11) n.s. n.s. n.s. n.s.
Attention
Index
.01 (.13) –.07 (.15) –.18 (.15) n.s. .10 (.14) .29 (.15) .35 (.15) n.s. n.s. n.s. p
= .020
Executive
Index
-.04 (.20) .08 (.24) –.08 (.24) n.s. -.02 (.21) .38 (.23) .13 (.25) n.s. n.s. n.s. n.s.
t-test * < .05, ** < .01, *** < .001
Note: HLM analyses correspond to pre-, post- and follow-up measures. Post-hoc were obtained by HLM per each group. FAST Functioning Assessment Scale Test,
BSL-23 Borderline Symptom List – 23, HARS Hamilton Anxiety Rating Scale, MADRS Montgomery-Asberg Depression Rating Scale, BIS Barrat Impulsivity Scale
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treatment as usual (TAU) might have prevented the obser-
vation of more robust differences.
Our results suggest that the general functional im-
provement observed in BPD is independent of clinical
and neuropsychological changes. Long-term follow-up
studies also show that clinical and general functioning
improvements are not always related because high rates
of clinical remission are not always associated with bet-
ter psychosocial functioning [3, 4]. These results are in
concordance with a recent study in bipolar disorder
where a delayed improvement on general functioning
was also found without clinical or neuropsychological
changes [20], and are strengthened even more by the
fact that conditions of the trial were controlled until the
end of the follow-up. What is clear is that psychosocial
functioning needs to be specifically addressed to obtain
a global recovery of BPD patients.
Psychoeducation impacted on clinical depressive and
anxiety symptoms as well as on attention domain com-
pared with CR. Our PE was partially based on “Aware-
ness of Borderline Personality Disorder”, the first step of
STEPPS programme that had previously been demon-
strated to improve clinical symptoms in BPD [27]. A
previous study comparing psychoeducational training
with waiting list also showed efficacy in symptoms such
as impulsivity or unstable relationships but no improve-
ment in psychosocial functioning [43]. It is worth mention-
ing that PE efficacy for clinical and neuropsychological
enhancement was observed with half of the sessions of CR
intervention.
The following limitations have to be taken into con-
sideration. The final sample size was limited due to
the high number of dropouts. Therefore, the present
findings need replication in larger samples. Such small
numbers did not allow us to perform analyses by domains
of the FAST, as done in a previous study [20]. Given that
this was a multicenter trial, the representativeness of the
sample with regard to subjects with BPD from Spain can
be acknowledged. Individual motivation to change and
groupal procedure are key factors for some types of
psychotherapeutic interventions. These factors were
not evaluated in this study, and could have affected the
findings, particularly for CR, which normally requires
additional efforts and a more personalized intervention.
In any case, CR was compared with an active interven-
tion although with lower duration and intensity, and
not a weaker treatment condition such as treatment as
usual or waiting list. The presence of a third arm with
an inactive treatment would probably have been useful
to confirm a significant efficacy of both interventions.
The influence of pharmacological effect was not evalu-
ated, but most patients were treated without differences
between treatment arms. Finally, we did not control
other non-specific factors that could affect psychological
functioning as social relationships, family support, regular
social activity stimulated by trainings, etc.
Conclusions
In summary, preliminary results from the present study
seem to suggest that both cognitive rehabilitation and psy-
choeducational interventions could be efficacious in sub-
jects with BPD to treat functional disabilities in daily life.
These interventions can be easily implemented in mental
health settings and provide advantages to improve general
functioning, which frequently remains affected after clin-
ical remission in long-term follow-up [2–4]. The present
results highlight the need for further research in order to
better determine the specific impact of these interventions
on psychosocial functioning in BPD. Specifically, investigat-
ing the combined effect of cognitive rehabilitation with
other BPD-specific psychotherapeutic models (i.e., DBT or
Mentalization-Based Therapy) would be of special interest.
Doing so may provide useful information to better deter-
mine if adding cognitive rehabilitation would amplify the
efficacy of well-established BPD treatments.
Fig. 2 General functional improvement measured by FAST scores in CG and PE groups in pre-, post- and 6 months follow-up measurements. Note
Fig. 2: Rounded and squared dots represent means and bars, standard errors. CR = Cognitive Rehabilitation; PE = Psychoeducational intervention. A time
effect was observed in the HLM analysis [F(2, 41.14) = 7.54, p = .002]. Post hoc analyses showed that FAST only improved significantly in the CR condition
(p = .018)
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